Planned sale

Danaher Corporation (DHR): Officer filed to sell ~$7.01M

McGrew Matthew, Officer at Danaher Corporation, filed to sell ~$7.01M of Danaher Corporation shares.

~$7.01M
planned to sell · 30K shares, around Oct 28, 2026
Planned for
Oct 28, 2026
Notice filed
Oct 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  2. Sep 2, 2026FDARecall: DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520
  3. Sep 2, 2026FDARecall: DxC 500i Clinical Analyzer Modules: 1. DxC 500 AU Module w/ISE, DxC 500i, Part No. C63522 2. DxC 500 AU Module, DxC 500i, Part No. C63521 3. Access 2 Module, D…
  4. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  5. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
  6. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  7. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  8. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel
  9. Oct 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.”
  10. Oct 19, 2026FDAFDA device clearance: Access MeMed BV
  11. Oct 20, 2026FDAFDA device clearance: Access BNP II
  12. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
  13. Oct 28, 2026Insider · 2 peopleInsiders: 4 sales (~$8.8M)

What came next

  1. Oct 30, 2026FDAFDA device clearance: Xpert® Hemorrhagic Fever Panel
  2. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.6%
  3. Nov 9, 2026Insider · 2 peopleInsiders: 2 sales (~$4.6M)
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

Which Danaher Corporation (DHR) insider traded, and how much?

McGrew Matthew, Officer at Danaher Corporation, filed to sell ~$7.01M of Danaher Corporation shares. 30K shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Oct 28, 2026. Notice filed: Oct 28, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data